Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Gilead Sciences has received a subpoena from the US Department of Justice requesting documents regarding its marketing and medical education programs for three of its HIV drugs.
Subscribe to our email newsletter
The documents relate to the drugs Truvada, Viread and Emtriva. Truvada is a combination of Viread and Emtriva. Truvada is for use in combination with other anti-HIV agents to treat HIV infection in adults
Recently there have been a number of investigations into the marketing practices of biotechnology companies. Intermune was accused of illegally promoting its lung disease drug but did not challenge the allegations and a division of Johnson & Johnson, Scios has allegedly improperly promoted frequent injections of its heart drug Natrecor in out-patient settings.
Gilead said it intends to comply with the subpoena and to cooperate in any related government investigation.